Amplifon stock holds above 12 euros as Italy stays firm
Published on 08/18/2026 at 22:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amplifon (IT0004056880) closed at 12.50 euros on August 18, 2026, up 0.08% on the day, while the FTSE MIB ended at 53,017.84, down 1.06%. The stock also appeared at 12.51 euros in a same-day performance table, reinforcing a narrow trading band for the session.
Italy trading keeps the tape tight
The session showed Amplifon with a last value of 12.51 euros versus a prior-day reference of 12.49 euros, equal to a 0.16% move in the daily performance table. That is a small gain, but it matters because the broader index move was negative on the same date and the stock still finished near its reference level.
For investors, the comparison is the key point: Amplifon rose while the FTSE MIB fell 1.06% on August 18, 2026. The shares therefore held relative strength inside a weaker Italian market, with the move supported by a quote close to 12.50 euros and a day-end reference of 12.46 euros in the index list.
Recent business context
The latest available earnings commentary in the search results points to FY2025, where revenue growth reached 1.7% at constant exchange rates and organic growth turned positive in Q4 across all regions. Management also said it expects a material margin improvement in 2026, with a cautious qualitative guide rather than a detailed numeric outlook.
A separate same-day item linked Amplifon India to a completed acquisition by Hearzap on August 18, 2026, a reminder that the group remains active in hearing-care consolidation. The report said the combined business is expected to generate more than INR 23 billion in revenue and that Hearzap is targeting about INR 2.5 billion by the end of the current financial year.
Hearing-care core
Amplifon’s business still rests on hearing solutions and audiology services, which is why pricing power, local clinic traffic, and the pace of integration in each market matter more than broad market slogans. The India update fits that pattern because the sector is still being shaped by regional scale and distribution density rather than one-off financial headlines.
On the chart, the shares stayed in a tight range around 12.50 euros on August 18, 2026, with the day moving between 12.46 euros and 12.51 euros in the available quote snapshots. That leaves the stock close to its intraday reference level rather than far from it, which can matter when investors are watching whether the name can build on a modest daily gain.
More on Amplifon stock
Amplifon sells hearing care through a retail network and clinical service model, so margins tend to depend on mix, utilization, and execution across geographies. The FY2025 commentary and the India transaction both point to a business still leaning on operating discipline and selective expansion.
Price and market view
As of August 18, 2026, Amplifon traded at 12.50 euros in the FTSE MIB list and 12.51 euros in the daily performance table. The company remained a mid-cap consumer healthcare name inside an index that closed at 53,017.84, giving the stock a visible but restrained place in the day’s market tape.
Fact box
Company: Amplifon S.p.A.
ISIN: IT0004056880
Ticker: AMP
Exchange: Borsa Italiana
Price (as of August 18, 2026, 5:35 p.m. CET): EUR 12.50
Market cap: EUR 2.8 billion
Sector / Industry: Health Care / Health Care Equipment & Supplies
Index membership: FTSE MIB
